Science & Technology
(U50)
BIOMEDICAL RESEARCH & LONGEVITY SOCIETY INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$10.2M
Total Revenue
$7.9M
Total Expenses
$42.9M
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
97.1%
Fundraising Efficiency
0.0%
Operating Reserve
65.18x
Liability-to-Asset
0.0%
Revenue Diversification
77.1%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $10.2M | $7.9M | $42.9M | 97.1% | 2 |
| 2022 | $8.0M | $7.3M | N/A | — | 2 |
| 2021 | $8.2M | $5.9M | N/A | — | 2 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.